Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Patient-Reported Outcome Measures in CKD Care: The Importance of Demonstrating Need and Value.

Elliott MJ, Hemmelgarn BR.

Am J Kidney Dis. 2019 Jun 11. pii: S0272-6386(19)30728-0. doi: 10.1053/j.ajkd.2019.04.014. [Epub ahead of print] No abstract available.

PMID:
31200974
2.

Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.

Tonelli M, Wiebe N, Kovesdy CP, James MT, Klarenbach SW, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Jun 6;20(1):204. doi: 10.1186/s12882-019-1351-9.

3.

Identifying Needs for Self-management Interventions for Adults With CKD and Their Caregivers: A Qualitative Study.

Donald M, Beanlands H, Straus S, Ronksley P, Tam-Tham H, Finlay J, MacKay J, Elliott M, Herrington G, Harwood L, Large CA, Large CL, Waldvogel B, Sparkes D, Delgado M, Tong A, Grill A, Novak M, James MT, Brimble KS, Samuel S, Hemmelgarn BR.

Am J Kidney Dis. 2019 Apr 2. pii: S0272-6386(19)30163-5. doi: 10.1053/j.ajkd.2019.02.006. [Epub ahead of print]

PMID:
30952486
4.

Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System.

James MT, Levey AS, Tonelli M, Tan Z, Barry R, Pannu N, Ravani P, Klarenbach SW, Manns BJ, Hemmelgarn BR.

JAMA Netw Open. 2019 Apr 5;2(4):e191795. doi: 10.1001/jamanetworkopen.2019.1795.

5.

Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Thomas C, Weaver RG, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

BMC Nephrol. 2019 Mar 29;20(1):110. doi: 10.1186/s12882-019-1269-2.

6.

Statin use and the risk of acute kidney injury in older adults.

Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Mar 25;20(1):103. doi: 10.1186/s12882-019-1280-7.

7.

Red cell distribution width associations with clinical outcomes: A population-based cohort study.

Tonelli M, Wiebe N, James MT, Naugler C, Manns BJ, Klarenbach SW, Hemmelgarn BR.

PLoS One. 2019 Mar 13;14(3):e0212374. doi: 10.1371/journal.pone.0212374. eCollection 2019.

8.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P.

CMAJ. 2019 Mar 11;191(10):E274-E282. doi: 10.1503/cmaj.181372.

9.

The association between payment model and specialist physicians' selection of patients with diabetes: a descriptive study.

Quinn AE, Edwards A, Senior P, McBrien KA, Hemmelgarn BR, Tonelli M, Au F, Ma Z, Weaver RG, Manns BJ.

CMAJ Open. 2019 Feb 18;7(1):E109-E116. doi: 10.9778/cmajo.20180171. Print 2019 Jan-Mar.

10.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852. Erratum in: JAMA Netw Open. 2019 Mar 1;2(3):e190147.

11.

Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis.

Harrison TG, Tam-Tham H, Hemmelgarn BR, Elliott M, James MT, Ronksley PE, Jun M.

Can J Cardiol. 2019 Jan;35(1):77-91. doi: 10.1016/j.cjca.2018.10.014. Epub 2018 Oct 29. Review.

PMID:
30595186
12.

Effectiveness and components of self-management interventions in adult cancer survivors: a protocol for a systematic review and planned meta-analysis.

Cuthbert CA, Samawi HH, Hemmelgarn BR, Cheung WY.

Syst Rev. 2018 Dec 20;7(1):238. doi: 10.1186/s13643-018-0902-7.

13.

Exploring structural barriers to diabetes self-management in Alberta First Nations communities.

Kulhawy-Wibe S, King-Shier KM, Barnabe C, Manns BJ, Hemmelgarn BR, Campbell DJT.

Diabetol Metab Syndr. 2018 Dec 3;10:87. doi: 10.1186/s13098-018-0385-7. eCollection 2018.

14.

Identification and Prioritization of Quality Indicators for Conservative Kidney Management.

Harrison TG, Tam-Tham H, Hemmelgarn BR, James MT, Sinnarajah A, Thomas CM.

Am J Kidney Dis. 2019 Feb;73(2):174-183. doi: 10.1053/j.ajkd.2018.08.014. Epub 2018 Oct 25.

PMID:
30482578
15.

Perceived Significance of Engagement in Research Prioritization Among Chronic Kidney Disease Patients, Caregivers, and Health Care Professionals: A Qualitative Study.

Elliott MJ, Goodarzi Z, Sale JEM, Wilhelm LA, Laupacis A, Hemmelgarn BR, Straus SE.

Can J Kidney Health Dis. 2018 Oct 19;5:2054358118807480. doi: 10.1177/2054358118807480. eCollection 2018.

16.

Sustaining knowledge translation interventions for chronic disease management in older adults: protocol for a systematic review and network meta-analysis.

Tricco AC, Moore JE, Beben N, Brownson RC, Chambers DA, Dolovich LR, Edwards A, Fairclough L, Glasziou PP, Graham ID, Hemmelgarn BR, Holmes B, Isaranuwatchai W, Lachance CC, Legare F, McGowan J, Majumdar SR, Presseau J, Squires JE, Stelfox HT, Strifler L, Thompson K, Van der Weijden T, Veroniki AA, Straus SE.

Syst Rev. 2018 Sep 15;7(1):140. doi: 10.1186/s13643-018-0808-4.

17.

The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study.

Cuthbert CA, Hemmelgarn BR, Xu Y, Cheung WY.

J Cancer Surviv. 2018 Dec;12(6):733-743. doi: 10.1007/s11764-018-0710-z. Epub 2018 Sep 6.

PMID:
30191524
18.

Long-term views on chronic kidney disease research priorities among stakeholders engaged in a priority-setting partnership: A qualitative study.

Elliott MJ, Sale JEM, Goodarzi Z, Wilhelm L, Laupacis A, Hemmelgarn BR, Straus SE.

Health Expect. 2018 Dec;21(6):1142-1149. doi: 10.1111/hex.12818. Epub 2018 Aug 15.

19.

Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.

Veroniki AA, Antony J, Straus SE, Ashoor HM, Finkelstein Y, Khan PA, Ghassemi M, Blondal E, Ivory JD, Hutton B, Gough K, Hemmelgarn BR, Lillie E, Vafaei A, Tricco AC.

PLoS One. 2018 Jun 18;13(6):e0198447. doi: 10.1371/journal.pone.0198447. eCollection 2018.

20.

Overview of Self-Management Resources Used by Canadian Chronic Kidney Disease Clinics: A National Survey.

Donald M, Gil S, Kahlon B, Beanlands H, Straus S, Herrington G, Manns B, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 May 22;5:2054358118775098. doi: 10.1177/2054358118775098. eCollection 2018.

21.

Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.

Tam-Tham H, Quinn RR, Weaver RG, Zhang J, Ravani P, Liu P, Thomas C, King-Shier K, Fruetel K, James MT, Manns BJ, Tonelli M, Murtagh FEM, Hemmelgarn BR.

Kidney Int. 2018 Sep;94(3):582-588. doi: 10.1016/j.kint.2018.03.007. Epub 2018 May 24.

PMID:
29803405
22.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

23.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

24.

Perceived Benefits and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disease Care: A Qualitative Descriptive Study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 Mar 23;5:2054358118763809. doi: 10.1177/2054358118763809. eCollection 2018.

25.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

26.

Self-management interventions for adults with chronic kidney disease: a scoping review.

Donald M, Kahlon BK, Beanlands H, Straus S, Ronksley P, Herrington G, Tong A, Grill A, Waldvogel B, Large CA, Large CL, Harwood L, Novak M, James MT, Elliott M, Fernandez N, Brimble S, Samuel S, Hemmelgarn BR.

BMJ Open. 2018 Mar 22;8(3):e019814. doi: 10.1136/bmjopen-2017-019814. Review.

27.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
28.

Association between Duration of Predialysis Care and Mortality after Dialysis Start.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M, Ravani P.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899. doi: 10.2215/CJN.11951017. Epub 2018 Mar 5.

29.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
30.

Reproducibility of clinical research in critical care: a scoping review.

Niven DJ, McCormick TJ, Straus SE, Hemmelgarn BR, Jeffs L, Barnes TRM, Stelfox HT.

BMC Med. 2018 Feb 21;16(1):26. doi: 10.1186/s12916-018-1018-6. Review.

31.
32.

Implementation and Evaluation of a Risk-Based Approach to Guide Chronic Kidney Disease Care: Protocol for a Multiphase Mixed-Methods Study.

Hemmelgarn BR, Smekal MD, Weaver RG, Thomas C, Benterud E, Tam K, Manns BJ, Tonelli M, Finlay J, Donald M, Tam-Tham H, Bello A, Tangri N, Quinn RR.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117753618. doi: 10.1177/2054358117753618. eCollection 2018.

33.

Proportion of women presenters at medical grand rounds at major academic centres in Canada: a retrospective observational study.

Buell D, Hemmelgarn BR, Straus SE.

BMJ Open. 2018 Jan 18;8(1):e019796. doi: 10.1136/bmjopen-2017-019796.

34.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.

35.

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Thompson S, Wiebe N, Klarenbach S, Pelletier R, Hemmelgarn BR, Gill JS, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

BMC Nephrol. 2017 Dec 8;18(1):357. doi: 10.1186/s12882-017-0773-5.

36.

Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.

James MT, Pannu N, Hemmelgarn BR, Austin PC, Tan Z, McArthur E, Manns BJ, Tonelli M, Wald R, Quinn RR, Ravani P, Garg AX.

JAMA. 2017 Nov 14;318(18):1787-1797. doi: 10.1001/jama.2017.16326.

37.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Jun M, Lix LM, Durand M, Dahl M, Paterson JM, Dormuth CR, Ernst P, Yao S, Renoux C, Tamim H, Wu C, Mahmud SM, Hemmelgarn BR; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

BMJ. 2017 Oct 17;359:j4323. doi: 10.1136/bmj.j4323.

38.

Disparity between Nephrologists' Opinions and Contemporary Practices for Community Follow-Up after AKI Hospitalization.

Karsanji DJ, Pannu N, Manns BJ, Hemmelgarn BR, Tan Z, Jindal K, Scott-Douglas N, James MT.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1753-1761. doi: 10.2215/CJN.01450217. Epub 2017 Oct 12.

39.

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT.

Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244. Epub 2017 Sep 28.

PMID:
28965748
40.

Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N, Jindal K, Tink W, Hemmelgarn BR.

Am J Kidney Dis. 2018 Jan;71(1):42-51. doi: 10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12.

PMID:
28912054
41.

Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Nov;70(5):696-704. doi: 10.1053/j.ajkd.2017.06.029. Epub 2017 Aug 31.

PMID:
28838766
42.

Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.

Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, Hemmelgarn BR, Yazdi F, D'Souza J, MacDonald H, Tricco AC.

BMJ Open. 2017 Jul 20;7(7):e017248. doi: 10.1136/bmjopen-2017-017248. Review.

43.

Trends in the Management of Patients With Kidney Failure in Alberta, Canada (2004-2013).

Chong CC, Tam-Tham H, Hemmelgarn BR, Weaver RG, Scott-Douglas N, Tonelli M, Quinn RR, Manns L, Manns BJ.

Can J Kidney Health Dis. 2017 Mar 22;4:2054358117698668. doi: 10.1177/2054358117698668. eCollection 2017.

44.

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.

Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, Hemmelgarn BR, Yazdi F, D'Souza J, MacDonald H, Tricco AC.

BMC Med. 2017 May 5;15(1):95. doi: 10.1186/s12916-017-0845-1.

45.

Barriers to care in patients with diabetes and poor glycemic control-A cross-sectional survey.

McBrien KA, Naugler C, Ivers N, Weaver RG, Campbell D, Desveaux L, Hemmelgarn BR, Edwards AL, Saad N, Nicholas D, Manns BJ.

PLoS One. 2017 May 1;12(5):e0176135. doi: 10.1371/journal.pone.0176135. eCollection 2017.

46.

In Reply to 'International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD'.

Jun M, Hemmelgarn BR.

Am J Kidney Dis. 2017 Jun;69(6):863-864. doi: 10.1053/j.ajkd.2017.02.368. Epub 2017 Apr 17. No abstract available.

PMID:
28427791
47.

Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

Donald M, King-Shier K, Tsuyuki RT, Al Hamarneh YN, Jones CA, Manns B, Tonelli M, Tink W, Scott-Douglas N, Hemmelgarn BR.

CMAJ Open. 2017 Mar 6;5(1):E205-E212. doi: 10.9778/cmajo.20160135. eCollection 2017 Jan-Mar.

48.

Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans.

Pialoux V, Poulin MJ, Hemmelgarn BR, Muruve DA, Chirico EN, Faes C, Sola DY, Ahmed SB.

Front Physiol. 2017 Mar 10;8:138. doi: 10.3389/fphys.2017.00138. eCollection 2017.

49.

Exploring the impact of financial barriers on secondary prevention of heart disease.

Dhaliwal KK, King-Shier K, Manns BJ, Hemmelgarn BR, Stone JA, Campbell DJ.

BMC Cardiovasc Disord. 2017 Feb 14;17(1):61. doi: 10.1186/s12872-017-0495-4.

50.

Financial barriers and adverse clinical outcomes among patients with cardiovascular-related chronic diseases: a cohort study.

Campbell DJ, Manns BJ, Weaver RG, Hemmelgarn BR, King-Shier KM, Sanmartin C.

BMC Med. 2017 Feb 15;15(1):33. doi: 10.1186/s12916-017-0788-6.

Supplemental Content

Loading ...
Support Center